Sign in

NCT06866782Recruiting

European Registry of Next Generation Imaging in Advanced Prostate Cancer

Source: ClinicalTrials.gov · Last updated 11 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The RING study is a European registry collecting real-world data on advanced prostate cancer (APC) imaging. It aims to evaluate the role of next-generation imaging (NGI), such as PET/CT and whole-body MRI, in detecting and monitoring the disease compared to conventional imaging. Men aged 18 or older with histologically confirmed prostate cancer are eligible to participate in the study if they require imaging to assess potential metastases, either at diagnosis or after relapse and sign a consent form. Patients will receive standard care with no experimental treatments. Imaging and treatment decisions will follow routine clinical practice. Data will be collected from medical records and analysed for research. This study will help doctors understand when NGI should be used, how it affects treatment decisions, and its impact on patient outcomes.

Status (registry)
Recruiting
Study type
Observational
Enrollment
600 (estimated)
First submitted
26 Feb 2025
Start date
17 Sept 2024
Primary completion date
23 Dec 2025
Lead sponsor
Fundacio Puigvert
NCT number
NCT06866782

What you commit to

  • Study type: Observational
  • Planned participants: 600
  • From 17 Sept 2024 to the primary completion date, 23 Dec 2025
  • 23 sites in 8 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with evidence of any other clinically significant disease or condition which in the opinion of the investigator discourages their participation in the study.

Other

  • Patients participating in other interventional or non-interventional study which requires NGI as a triage test for metastatic assessment.
  • Patients who will not be able to complete the study.

Who the study is looking for

  • Adult male patients (≥18 years with no upper age limit).
  • Histologically proven prostate cancer.
  • Patients who require imaging exploration (conventional, Next-Generation Imaging (NGI), or their combination) at high risk for harbouring metastatic deposits at the hormone-sensitive stage, either at the diagnostic workout of a "naïve" patient or at biochemical relapse/progression after local treatment.
  • Patients who authorize their participation in the study by signing a written informed consent form (ICF).

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (23)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universitair Ziekenhuis Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumNot yet recruiting
Bonn University Hospital
Coordinator of this site? Confirm its status
BonnGermanyNot yet recruiting
Martini Klinik
Coordinator of this site? Confirm its status
HamburgGermanyNot yet recruiting
München LMU L MU-University Clinic
Coordinator of this site? Confirm its status
MunichGermanyNot yet recruiting
Urologische Klinik München- Planegg
Coordinator of this site? Confirm its status
PlaneggGermanyNot yet recruiting
Universitätsklinik Tübingen
Coordinator of this site? Confirm its status
TübingenGermanyNot yet recruiting
Hospital de la Santa Creu i Sant Pau
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Fundació Puigvert
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Universitario Reina Sofia
Coordinator of this site? Confirm its status
CórdobaSpainNot yet recruiting
Hospital Universitario Ramón y Cajal
Coordinator of this site? Confirm its status
MadridSpainNot yet recruiting
Hospital Universitario La Paz
Coordinator of this site? Confirm its status
MadridSpainNot yet recruiting
Hospital Universitario de Canarias
Coordinator of this site? Confirm its status
San Cristóbal de La LagunaSpainRecruiting
Hospital Universitario Marqués de Valdecilla
Coordinator of this site? Confirm its status
SantanderSpainNot yet recruiting
Hospital Clínico Universitario de Santiago
Coordinator of this site? Confirm its status
Santiago de CompostelaSpainNot yet recruiting
Hospital Center University De Lille
Coordinator of this site? Confirm its status
LilleFranceNot yet recruiting
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
LyonFranceNot yet recruiting
University Hospitals Pitié Salpêtrière
Coordinator of this site? Confirm its status
ParisFranceNot yet recruiting
IRCCS Universit of Bologna
Coordinator of this site? Confirm its status
BolognaItalyNot yet recruiting
Azienda Ospedaliero-Universitaria Careggi
Coordinator of this site? Confirm its status
FlorenceItalyRecruiting
IRCCS Ospedale San Raffaele
Coordinator of this site? Confirm its status
MilanItalyNot yet recruiting
ERASMUS MC & Franciscus Hospital
Coordinator of this site? Confirm its status
RotterdamNetherlandsNot yet recruiting
Uniwersytet Jagiellonski Collegium Medicum
Coordinator of this site? Confirm its status
KrakowPolandNot yet recruiting
Skånes universitetssjukhus Malmö
Coordinator of this site? Confirm its status
MalmöSwedenNot yet recruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.